Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion type Assertion NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_head.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion description "[This study compared the number, cellular origin and procoagulant activity of MPs on DVT patients in different clinical situations: at diagnosis (n = 9, 5F/4M; mean age = 41.11), 1-3 years after warfarin withdrawal (n = 10, 7F/3M; mean age = 32.90), associated to antiphospholipid syndrome (APS; n = 11, 9F/2M; mean age = 33.82), or asymptomatic carriers of Factor V Leiden (FVL; n = 7, 7F/0M; mean age = 34.00) vs healthy controls (CTR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_provenance.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion evidence source_evidence_literature NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_provenance.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion SIO_000772 19811220 NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_provenance.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion wasDerivedFrom befree-20140225 NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_provenance.
- NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_assertion wasGeneratedBy ECO_0000203 NP929193.RAxn1vN5c_xP2gglWC6LkG5IbIope5oYVyZEOHXVa3WUw130_provenance.